CONGRESS PRESENTATIONS

CONGRESS PRESENTATIONS

CROI 2023

Conference on Retroviruses and Opportunistic Infections

February 19 - 22, 2023 
Hybrid

  • Cabotegravir

    Felizarta F, et al.

    Thigh Injections of Cabotegravir+Rilpivirine in Virally Suppressed Adults with HIV-1. Presented at the 30th Conference on Retroviruses and Opportunistic Infections (CROI), February 19-22, 2023, Seattle, Washington. TBD.

    Ramgopal M, et al.

    Solar 12-Month Results - Randomized Switch Trial of CAB+RPV LA vs. Oral B/FTC/TAF. Presented at the 30th Conference on Retroviruses and Opportunistic Infections (CROI), February 19-22, 2023, Seattle, Washington. Oral Presentation.

    Tan D, et al.

    Weight and Metabolic Changes with Cabotegravir+Rilpivirine Long-Acting or Bictegravir. Presented at the 30th Conference on Retroviruses and Opportunistic Infections (CROI), February 19-22, 2023, Seattle, Washington. Oral Presentation.

  • Dolutegravir

    Chandasana H, et al.

    Model Informed Dolutegravir Dose Selection in Peds with 1st Generation INSTI-R. Presented at the 30th Conference on Retroviruses and Opportunistic Infections (CROI), February 19-22, 2023, Seattle, Washington. Poster.

    Roen AO, et al.

    Chronic Liver Inflammation and Use of Contemporary Art Among Persons Living with HIV. Presented at the 30th Conference on Retroviruses and Opportunistic Infections (CROI), February 19-22, 2023, Seattle, Washington. Poster.

    Underwood M, et al.

    Comparison of Telomere Length Changes Over 48 Weeks in SALSA Study: DTG/3TC vs CAR. Presented at the 30th Conference on Retroviruses and Opportunistic Infections (CROI), February 19-22, 2023, Seattle, Washington. Poster.

  • Disease State

    Anderson K, et al.

    Timing of Vertical Transmission with High Maternal Antiretroviral Treatment Coverage. Presented at the 30th Conference on Retroviruses and Opportunistic Infections (CROI), February 19-22, 2023, Seattle, Washington. Poster.

    Tusch E, et al.

    Trends in Mortality in People Living with HIV in an International Cohort (RESPOND). Presented at the 30th Conference on Retroviruses and Opportunistic Infections (CROI), February 19-22, 2023, Seattle, Washington. Poster.

  • Pipeline

    Leone P, et al.

    Impact of Baseline Factors on Virologic Response to bNAB VH3810109 (N6LS) in BANNER. Presented at the 30th Conference on Retroviruses and Opportunistic Infections (CROI), February 19-22, 2023, Seattle, Washington. Poster.

This content was acquired following an unsolicited medical information enquiry by a healthcare professional. Always consult the product information for your country, before prescribing a ViiV medicine. ViiV does not recommend the use of our medicines outside the terms of their license. In some cases, the scientific Information requested and downloaded may relate to the use of our medicine(s) outside of their license.

My MSL

Enter zip code to find your MSL contact.